about
Investigational antimicrobial agents of 2013.Tackling antibiotic resistance.Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant BacteriaForgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.Reply to Furlan et al., "Importance of Sequencing To Determine Functional blaTEM Variants".In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.Game Changers: New β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria.Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested In Vitro with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam.In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.Detection systems for carbapenemase gene identification should include the SME serine carbapenemaseEpidemiology of β-Lactamase-Producing PathogensCritical analysis of antibacterial agents in clinical developmentA Meandering Path from Biochemist to MicrobiologistPast and Present Perspectives on β-LactamasesA Standard Numbering Scheme for Class C β-LactamasesPublisher Correction: Interplay between β-lactamases and new β-lactamase inhibitorsInterplay between β-lactamases and new β-lactamase inhibitorsActivity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance
P50
Q34375204-AA116596-4F28-469F-BFDA-4FE58ADDA69EQ34390844-76E44485-AAE2-446A-AEFA-19070E99B29AQ37036459-80B5202C-3C8B-430F-82A4-63507FD8AC7CQ37270946-6119963D-6F5C-4562-8FE0-C5268500BE48Q37971365-4D236C3A-70DA-4BA7-BEDD-2B5BBB11CDEEQ40633420-ABB703CA-B282-4137-8750-9AF2C14F101CQ42358828-0239F0E0-C425-4172-919A-BB1E521DDE55Q43126004-9F72B19F-E143-4EB0-8BB7-CECF64CA6820Q43144149-4E8471D3-BDDF-42F4-A753-3EE39E831CABQ48133913-4B4EC9D2-7CB2-4369-A563-7CD0A7827CB4Q48355486-34B06245-6B96-4DE8-B6B9-14BF76742B48Q52841787-7C86A961-0DDC-4828-8654-09578A9247E3Q53707135-9DC34386-45A7-4AFE-A905-424190C400B5Q85634232-9623FD37-4758-49E8-BC1E-D159D8F54218Q89899478-D8D45857-DEF7-49F7-A26A-A62D6AAE8B3AQ90171494-56874BAB-02FC-4073-BCAA-DDAEBD475A3DQ90240556-0C43CBC3-6EA3-452B-8024-F9A796D26D29Q90645349-974D843D-0783-4DCB-9A87-A3408E569ED3Q91233373-3EEB6855-A6E3-43A1-8D99-BFAACCA7EA7CQ91652973-F3CB6473-665A-4A2F-A8C7-F87F3288DDCEQ92150103-B2065E34-8DB8-41D3-8140-594543809E18Q92727457-3FB4E6AE-5302-4999-81F5-44D1EF368CC0
P50
description
American biochemist
@en
wetenschapper
@nl
name
Karen Bush
@ast
Karen Bush
@en
Karen Bush
@es
Karen Bush
@nl
type
label
Karen Bush
@ast
Karen Bush
@en
Karen Bush
@es
Karen Bush
@nl
prefLabel
Karen Bush
@ast
Karen Bush
@en
Karen Bush
@es
Karen Bush
@nl
P244
P268
P269
P106
P21
P213
0000 0004 5981 4412
P214
16148449520315690254
P244
nb2011009783
P268
P269
P31
P496
0000-0002-7843-2474
P734
P735
P7859
lccn-nb2011009783